SCHEMBL2877700

SCHEMBL2877700

N#Cc1nccnc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29350921 0.80 ALDH1A1 (0.38)
SCHEMBL217939 0.80 ALDH1A1 (0.38)
SCHEMBL5679719 0.74
Pyrazine SCHEMBL27517504 0.72 ALDH1A1 (0.43)
SCHEMBL29460954 0.70
SCHEMBL136280 0.70
SCHEMBL27835683 0.70 ALDH1A1 (0.39)
SCHEMBL7939455 0.70
SCHEMBL22876719 0.70
SCHEMBL12389423 0.70 NOS3 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1023278-A1 PROCESS FOR PREPARING SUBSTITUTED PYRAZINE COMPOUNDS Abbott Laboratories (US) 2000-08-02 EP claimed
WO-1999019314-A1 PROCESS FOR PREPARING SUBSTITUTED PYRAZINE COMPOUNDS ABBOTT LABORATORIES (US) 1999-04-22 WO claimed
EP-0399856-B1 Pteridin-4 (3H)-ones, processes for their preparation and medicaments containing them LIPHA (FR) 1995-08-09 EP claimed
EP-0399856-A1 Pteridin-4 (3H)-ones, processes for their preparation and medicaments containing them LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) 1990-11-28 EP claimed
EP-4532486-A1 PYRIDINE CHECKPOINT KINASE 1 (CHK1) INHIBITORS AND USES THEREOF Boundless Bio, Inc. (US) 2025-04-09 EP disclosed
EP-4396191-A1 COMPOUNDS USEFUL IN MODULATION OF AHR SIGNALLING JAGUAHR THERAPEUTICS PTE LTD (SG) 2024-07-10 EP disclosed
WO-2023033740-A9 COMPOUNDS USEFUL IN MODULATION OF AHR SIGNALLING JAGUAHR THERAPEUTICS PTE LTD (SG) 2023-12-28 WO disclosed
US-11844854-B2 Fragrance materials THE PROCTER & GAMBLE COMPANY (US) 2023-12-19 US disclosed
CN-111995591-B Dicyanopyrazine compound, light-emitting material, and light-emitting element using same 国立大学法人九州大学 2023-12-08 CN disclosed
CN-111995589-B Process for producing 2, 5-dicyano-3, 6-dihalopyrazine 国立大学法人九州大学 2023-12-05 CN disclosed
WO-2023230477-A1 PYRIDINE CHECKPOINT KINASE 1 (CHK1) INHIBITORS AND USES THEREOF BOUNDLESS BIO, INC. (US) 2023-11-30 WO disclosed
WO-2023033740-A1 COMPOUNDS USEFUL IN MODULATION OF AHR SIGNALLING JAGUAHR THERAPEUTICS PTE LTD (SG) 2023-03-09 WO disclosed
EP-0132577-A1 Colour-photographic recording material with a dye releaser for blue-green dyestuffs, a colour image obtained with these dyestuffs and the dyestuffs themselves Agfa-Gevaert AG (DE) 1985-02-13 EP disclosed
EP-0048001-B1 METHOD FOR PREPARING N-(4-(((2,4-DIAMINO-6-PTERIDINYL)-METHYL)METHYLAMINO)BENZOYL)GLUTAMIC ACID Farmos Group Ltd. (FI) 1984-12-19 EP disclosed
EP-0048001-A1 Method for preparing N-(4-(((2,4-diamino-6-pteridinyl)-methyl)methylamino)benzoyl)glutamic acid Farmos Group Ltd. (FI) 1982-03-24 EP disclosed
US-4112094-A ANTIALLERGENS AMERICAN HOME PRODUCTS CORPORATION (US) 1978-09-05 US disclosed
US-4079056-A REACTING 2,4-DIAMINO-6-PTERIDINE-METHANOL-HBR WITH TRIPHENYLPHOSPHINE DIBROMIDE OR PHOSPHORUS TRIBROMIDE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH, EDUCATION AND WELFARE (US) 1978-03-14 US disclosed
US-4077957-A INTERMEDIATE FOR METHOTREXATE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH, EDUCATION AND WELFARE (US) 1978-03-07 US disclosed
US-3954753-A SEDATIVES, MUSCLE RELAXANTS, ANTICONVULSANTS HOFFMANN-LA ROCHE INC. (US) 1976-05-04 US disclosed
US-3932404-A REACTION WITH AMMONIA AND A BASIC AGENT PECHINEY UGINE KUHLMANN (FR) 1976-01-13 US disclosed